ANDA 88625, held by Chartwell Rx. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 88625 (Phentermine Hydrochloride), held by Chartwell Rx, was first approved by FDA on Aug 23, 1984, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 23, 1984 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride37.5MG ยท capsule;oral | Phentermine Hydrochloride | Discontinued |
| Oct 6, 2000 | Supplement 16Manufacturing | Approved | None posted |
| Nov 3, 1998 | Supplement 14Labeling | Approved | None posted |
| Aug 19, 1998 | Supplement 13Labeling | Approved | None posted |
| Apr 8, 1998 | Supplement 12Labeling | Approved | None posted |
| Dec 19, 1997 | Supplement 11Labeling | Approved | None posted |
| Oct 16, 1992 | Supplement 10Manufacturing | Approved | None posted |
| Aug 16, 1989 | Supplement 8Labeling | Approved | None posted |
| May 4, 1989 | Supplement 6Labeling | Approved | None posted |
| May 4, 1989 | Supplement 7Labeling | Approved | None posted |
| Jun 27, 1988 | Supplement 4Manufacturing | Approved | None posted |
| Jun 27, 1988 | Supplement 5Manufacturing | Approved | None posted |
| Aug 23, 1984 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters